These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 22079083

  • 41. Therapeutics that directly increase SMN expression to treat spinal muscular atrophy.
    Shababi M, Mattis VB, Lorson CL.
    Drug News Perspect; 2010 Oct; 23(8):475-82. PubMed ID: 21031163
    [Abstract] [Full Text] [Related]

  • 42. Density, calibre and ramification of muscle capillaries are altered in a mouse model of severe spinal muscular atrophy.
    Somers E, Stencel Z, Wishart TM, Gillingwater TH, Parson SH.
    Neuromuscul Disord; 2012 May; 22(5):435-42. PubMed ID: 22153987
    [Abstract] [Full Text] [Related]

  • 43. Abolishing Trp53-dependent apoptosis does not benefit spinal muscular atrophy model mice.
    Tsai MS, Chiu YT, Wang SH, Hsieh-Li HM, Li H.
    Eur J Hum Genet; 2006 Mar; 14(3):372-5. PubMed ID: 16391561
    [Abstract] [Full Text] [Related]

  • 44. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy.
    Sun Y, Grimmler M, Schwarzer V, Schoenen F, Fischer U, Wirth B.
    Hum Mutat; 2005 Jan; 25(1):64-71. PubMed ID: 15580564
    [Abstract] [Full Text] [Related]

  • 45. Therapeutic strategies for the treatment of spinal muscular atrophy.
    Cherry JJ, Androphy EJ.
    Future Med Chem; 2012 Sep; 4(13):1733-50. PubMed ID: 22924510
    [Abstract] [Full Text] [Related]

  • 46. [Quantitative analysis of the genes determining spinal muscular atrophy].
    Nagymihály M, Herczegfalvi A, Tímár L, Karcagi V.
    Ideggyogy Sz; 2009 Nov 30; 62(11-12):390-7. PubMed ID: 20025129
    [Abstract] [Full Text] [Related]

  • 47. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).
    Wirth B.
    Hum Mutat; 2000 Nov 30; 15(3):228-37. PubMed ID: 10679938
    [Abstract] [Full Text] [Related]

  • 48. Neurocalcin Delta Suppression Protects against Spinal Muscular Atrophy in Humans and across Species by Restoring Impaired Endocytosis.
    Riessland M, Kaczmarek A, Schneider S, Swoboda KJ, Löhr H, Bradler C, Grysko V, Dimitriadi M, Hosseinibarkooie S, Torres-Benito L, Peters M, Upadhyay A, Biglari N, Kröber S, Hölker I, Garbes L, Gilissen C, Hoischen A, Nürnberg G, Nürnberg P, Walter M, Rigo F, Bennett CF, Kye MJ, Hart AC, Hammerschmidt M, Kloppenburg P, Wirth B.
    Am J Hum Genet; 2017 Feb 02; 100(2):297-315. PubMed ID: 28132687
    [Abstract] [Full Text] [Related]

  • 49. Astrocytes influence the severity of spinal muscular atrophy.
    Rindt H, Feng Z, Mazzasette C, Glascock JJ, Valdivia D, Pyles N, Crawford TO, Swoboda KJ, Patitucci TN, Ebert AD, Sumner CJ, Ko CP, Lorson CL.
    Hum Mol Genet; 2015 Jul 15; 24(14):4094-102. PubMed ID: 25911676
    [Abstract] [Full Text] [Related]

  • 50. Is RNA manipulation a viable therapy for spinal muscular atrophy?
    Horne C, Young PJ.
    J Neurol Sci; 2009 Dec 15; 287(1-2):27-31. PubMed ID: 19758605
    [Abstract] [Full Text] [Related]

  • 51. A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice.
    Workman E, Saieva L, Carrel TL, Crawford TO, Liu D, Lutz C, Beattie CE, Pellizzoni L, Burghes AH.
    Hum Mol Genet; 2009 Jun 15; 18(12):2215-29. PubMed ID: 19329542
    [Abstract] [Full Text] [Related]

  • 52. AAV9-Stathmin1 gene delivery improves disease phenotype in an intermediate mouse model of spinal muscular atrophy.
    Villalón E, Kline RA, Smith CE, Lorson ZC, Osman EY, O'Day S, Murray LM, Lorson CL.
    Hum Mol Genet; 2019 Nov 15; 28(22):3742-3754. PubMed ID: 31363739
    [Abstract] [Full Text] [Related]

  • 53. Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy.
    Zhou H, Meng J, Malerba A, Catapano F, Sintusek P, Jarmin S, Feng L, Lu-Nguyen N, Sun L, Mariot V, Dumonceaux J, Morgan JE, Gissen P, Dickson G, Muntoni F.
    J Cachexia Sarcopenia Muscle; 2020 Jun 15; 11(3):768-782. PubMed ID: 32031328
    [Abstract] [Full Text] [Related]

  • 54. Hypothermia improves disease manifestations in SMA mice via SMN augmentation.
    Tsai LK, Chen CL, Tsai YC, Ting CH, Chien YH, Lee NC, Hwu WL.
    Hum Mol Genet; 2016 Feb 15; 25(4):631-41. PubMed ID: 26647309
    [Abstract] [Full Text] [Related]

  • 55. Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy.
    Passini MA, Bu J, Richards AM, Treleaven CM, Sullivan JA, O'Riordan CR, Scaria A, Kells AP, Samaranch L, San Sebastian W, Federici T, Fiandaca MS, Boulis NM, Bankiewicz KS, Shihabuddin LS, Cheng SH.
    Hum Gene Ther; 2014 Jul 15; 25(7):619-30. PubMed ID: 24617515
    [Abstract] [Full Text] [Related]

  • 56. Tissue-specific models of spinal muscular atrophy confirm a critical role of SMN in motor neurons from embryonic to adult stages.
    Laird AS, Mackovski N, Rinkwitz S, Becker TS, Giacomotto J.
    Hum Mol Genet; 2016 May 01; 25(9):1728-38. PubMed ID: 26908606
    [Abstract] [Full Text] [Related]

  • 57. Intraperitoneal delivery of a novel drug-like compound improves disease severity in severe and intermediate mouse models of Spinal Muscular Atrophy.
    Osman EY, Rietz A, Kline RA, Cherry JJ, Hodgetts KJ, Lorson CL, Androphy EJ.
    Sci Rep; 2019 Feb 07; 9(1):1633. PubMed ID: 30733501
    [Abstract] [Full Text] [Related]

  • 58. Muscle-specific SMN reduction reveals motor neuron-independent disease in spinal muscular atrophy models.
    Kim JK, Jha NN, Feng Z, Faleiro MR, Chiriboga CA, Wei-Lapierre L, Dirksen RT, Ko CP, Monani UR.
    J Clin Invest; 2020 Mar 02; 130(3):1271-1287. PubMed ID: 32039917
    [Abstract] [Full Text] [Related]

  • 59. Increasing SMN levels using the histone deacetylase inhibitor SAHA ameliorates defects in skeletal muscle microvasculature in a mouse model of severe spinal muscular atrophy.
    Somers E, Riessland M, Schreml J, Wirth B, Gillingwater TH, Parson SH.
    Neurosci Lett; 2013 Jun 07; 544():100-4. PubMed ID: 23583590
    [Abstract] [Full Text] [Related]

  • 60. Notch Signaling Mediates Astrocyte Abnormality in Spinal Muscular Atrophy Model Systems.
    Ohuchi K, Funato M, Yoshino Y, Ando S, Inagaki S, Sato A, Kawase C, Seki J, Saito T, Nishio H, Nakamura S, Shimazawa M, Kaneko H, Hara H.
    Sci Rep; 2019 Mar 06; 9(1):3701. PubMed ID: 30842449
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.